Carc/Rarc Mapping Using AI Tools
DOI:
https://doi.org/10.63282/3050-9416.IJAIBDCMS-V7I1P115Keywords:
Healthcare Analytics, X12, EDI Transactions, Claim Adjudication, Artificial IntelligenceAbstract
CARC and RARC are two of the core code sets used in healthcare claims adjudication. They explain why a claim was paid, denied, or adjusted. Your search results confirm this across multiple authoritative sources. CARCs explain the reason for a financial adjustment on a claim or service line. They tell you why the payer changed the billed amount (denied, reduced, bundled, not covered, etc.). They appear on ERAs (Electronic Remittance Advice) and EOBs. They are standardized across the industry and maintained by X12. Remittance Advice Remark Codes (RARCs) are used to provide additional explanation for an adjustment already described by a Claim Adjustment Reason Code (CARC) or to convey information about remittance processing. Each RARC identifies a specific message as shown in the Remittance Advice Remark Code List. There are two types of RARCs, supplemental and informational. The majority of the RARCs are supplemental; these are generally referred to as RARCs without further distinction. Supplemental RARCs provide additional explanation for an adjustment already described by a CARC. The second type of RARC is informational.
References
[1] X12.org, “Remittance Advice Remark,”. [Online]. Available: Remittance Advice Remark Codes | X12.
[2] CMS.Gov,”Health Care Payment and Remittance Advice”.[Online] Available : https://www.cms.gov/medicare/coding-billing/electronic-billing/health-care-payment-remittance-advice.
[3] Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115–118. https://doi.org/10.1038/nature21056
[4] Kourou, K., Exarchos, T. P., Exarchos, K. P., Karamouzis, M. V., & Fotiadis, D. I. (2015). Machine learning applications in cancer prognosis and prediction. Computational and Structural Biotechnology Journal, 13, 8–17. https://doi.org/10.1016/j.csbj.2014.11.005
[5] Litjens, G., Kooi, T., Bejnordi, B. E., Setio, A. A. A., Ciompi, F., Ghafoorian, M., … Sánchez, C. I. (2017). A survey on deep learning in medical image analysis. Medical Image Analysis, 42, 60–88. https://doi.org/10.1016/j.media.2017.07.005
[6] Coudray, N., Ocampo, P. S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., … Tsirigos, A. (2018). Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning. Nature Medicine, 24(10), 1559–1567. https://doi.org/10.1038/s41591-018-0177-5
[7] Bibault, J.-E., Giraud, P., & Burgun, A. (2016). Big data and machine learning in radiation oncology: State of the art and future prospects. Cancer Letters, 382(1), 110–117. https://doi.org/10.1016/j.canlet.2016.05.033
[8] Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., … Greene, C. S. (2018). Opportunities and obstacles for deep learning in biology and medicine. Journal of The Royal Society Interface, 15(141), 20170387. https://doi.org/10.1098/rsif.2017.0387
[9] LeCun, Y., Bengio, Y., & Hinton, G. (2015). Deep learning. Nature, 521(7553), 436–444. https://doi.org/10.1038/nature14539
[10] Miotto, R., Wang, F., Wang, S., Jiang, X., & Dudley, J. T. (2017). Deep learning for healthcare: Review, opportunities and challenges. Briefings in Bioinformatics, 19(6), 1236–1246. https://doi.org/10.1093/bib/bbx044
[11] Topol, E. J. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56. https://doi.org/10.1038/s41591-018-0300-7
[12] Kather, J. N., Krisam, J., Charoentong, P., Luedde, T., Herpel, E., Weis, C.-A., … Halama, N. (2019). Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study. PLoS Medicine, 16(1), e1002730. https://doi.org/10.1371/journal.pmed.100273
